Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Cash & Current Investments: 2020-2025

Historic Cash & Current Investments for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $155.1 million.

  • GeneDx Holdings' Cash & Current Investments rose 33.16% to $155.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $590.0 million, marking a year-over-year increase of 26.50%. This contributed to the annual value of $141.2 million for FY2024, which is 8.48% up from last year.
  • Latest data reveals that GeneDx Holdings reported Cash & Current Investments of $155.1 million as of Q3 2025, which was up 15.25% from $134.6 million recorded in Q2 2025.
  • GeneDx Holdings' Cash & Current Investments' 5-year high stood at $461.3 million during Q3 2021, with a 5-year trough of $26.5 million in Q2 2021.
  • Moreover, its 3-year median value for Cash & Current Investments was $134.6 million (2025), whereas its average is $140.1 million.
  • As far as peak fluctuations go, GeneDx Holdings' Cash & Current Investments surged by 40,363.55% in 2021, and later tumbled by 69.06% in 2022.
  • Quarterly analysis of 5 years shows GeneDx Holdings' Cash & Current Investments stood at $400.6 million in 2021, then slumped by 69.06% to $123.9 million in 2022, then climbed by 5.01% to $130.1 million in 2023, then climbed by 8.48% to $141.2 million in 2024, then surged by 33.16% to $155.1 million in 2025.
  • Its last three reported values are $155.1 million in Q3 2025, $134.6 million for Q2 2025, and $159.2 million during Q1 2025.